CRISPR/Cas9 technology generated a CGC to CAG change resulting in an arginine to glutamine substitution at amino acid 728 (p.R728Q) in exon 19. GRCm39 has the CGC to CAG mutation resulting in the R to Q substitution at amino acid 729. The p.R728Q mutation was identified in an intractable childhood epilepsy patient.